Managing Diverse Hematologic Malignancies at #ASH24

Complex Cases in the Community Clinic

Managing Diverse Hematologic Malignancies

Register Now
  • Friday, December 6, 2024
  • 3:30 pm - 5:30 pm PT
  • Room: Grand Ballroom 2-4
  • Marriott Marquis San Diego Marina | San Diego, California
  • Hybrid
Overview

Join us for an exciting symposium that will emulate a typical day in the life of a community hematologist or oncologist, highlighting the diversity of hematologic malignancies and the complex decisions that practitioners face daily through a series of patient cases. A panel of expert hematologists/oncologists will evaluate challenging patient scenarios using recent clinical data, treatment guidelines, and best practices to optimize access to care. The symposium will emphasize patient-centric care and shared decision-making as key priorities, addressing the practical challenges that busy community clinicians often encounter. By highlighting real-world cases and evidence-based strategies, the event aims to promote the integration of innovative treatments and improve patient outcomes in the community setting.
Register Now
Speakers
Speaker Image
Matthew Matasar, MD
MODERATOR

Professor

Rutgers Robert Wood Johnson Medical School

Chief, Division of Blood Disorders

Rutgers Cancer Institute of New Jersey and RJW Barnabas Health

New Brunswick, New Jersey, United States

Speaker Image
Chan Cheah, MBBS, DMSc
PANELIST

Professor of Haematology

Sir Charles Gairdner Hospital

Perth, Australia

Speaker Image
Luciano Costa, MD, PhD
PANELIST

Mary and Bill Battle Professor in Multiple Myeloma

Director, Multiple Myeloma Program

O’Neal Comprehensive Cancer Center

The University of Alabama at Birmingham

Birmingham, Alabama, United States

Speaker Image
Nisha S. Joseph, MD
PANELIST

Assistant Professor

Department of Hematology and Medical Oncology

Winship Cancer Institute

Emory University

Atlanta, Georgia,

United States

Speaker Image
Chaitra Ujjani, MD
PANELIST

Clinical Director of Lymphoma

Professor

Fred Hutchinson Cancer Center

Clinical Professor

University of Washington

Seattle, Washington,

United States

Agenda

3:00 pm

Meal and Registration

Matthew Matasar, MD

3:30 pm

Grab Your Coffee: Clinic Is Starting

Matthew Matasar, MD

3:40 pm

Multiple Myeloma in the Morning

Nisha S. Joseph, MD Luciano Costa, MD, PhD

4:10 pm

DLBCL in the Midday

Chan Cheah, MBBS, DMSc Matthew Matasar, MD

4:40 pm

Finishing the Day With CLL

Chaitra Ujjani, MD

5:10 pm

Charting at the End of the Day-Audience Q&A

All Faculty

5:30 pm

Program Conclusion

Register Now
333 W Harbor Dr, Room: Grand Ballroom 2-4, San Diego, California, 92101-7700
United States
Get Directions
Program Information
Accreditation Statement
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Accreditation logos
Accreditation logos
[bold]For Physicians[/bold] [break] Medscape, LLC designates this live activity for a maximum of 2.0 [italic]AMA PRA Category 1 Credits[/italic]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [break] [break] [bold]For Nurses[/bold] [break] Awarded 2.0 contact hour(s) of nursing continuing professional development for RNs and APNs. [break] [break] [bold]For Pharmacists[/bold] [break] Medscape designates this continuing education activity for 2.0 contact hour(s) (0.200 CEUs) (Universal Activity Number: JA0007105-0000-24-314-L01-P).
Learning Objectives
Upon completion of this activity, participants will: [break] Have increased knowledge regarding the[LIST] [ITEM]Standards of care in hematologic malignancies[/LIST] [break] Have greater competence related to[LIST] [ITEM]Managing hematologic malignancies in community-based practice[/LIST] [break] Demonstrate greater confidence in their ability to[LIST] [ITEM]Individualize management of hematologic malignancies with a patient-centric approach[/LIST]
Goal Statement
The goal of this activity is for learners to be better able to assess clinical data and how it may be applied to daily management decisions in myeloma and lymphoma.
Target Audience
This educational activity is intended for an audience of hematologist/oncologists, nurses, nurse practitioners, pharmacists, and other members of the hematology/oncology care team in the United States.

A Friday Satellite Symposium on Hematology, preceding the 66th ASH Annual Meeting and Exposition.

Supported by an independent educational grant from Incyte Corporation and Sanofi.